Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancers
Yi Ding(Nankai University), Xiao‐Fan Wang(Shanghai University), Handan Xiang(Duke University), Kris C. Wood(Duke University), Lifeng Yuan(Duke Medical Center), Chang Gong(Sun Yat-sen University), Qi-Jing Li(Agency for Science, Technology and Research), Kevin Lin(The University of Texas MD Anderson Cancer Center), Qian‐Fei Wang(Chinese Academy of Sciences), Junying Chen(Sun Yat-sen University), Pinpin Sui(Chinese Academy of Sciences), Rui Chen(Capital Medical University), Tao Yin(Wuhan Union Hospital), Peter B. Alexander(Duke Medical Center), Erwei Song(Sun Yat-sen University), Gehao Liang(Sun Yat-sen University), De Huang(University of Science and Technology of China)
Cited by 35
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Signaling cross-talk between TGF-β/BMP and other pathways
|Cell Research|2008|1k
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
|Clinical Cancer Research|2009|435